Improving Clinical Practice: The Importance of Guideline Development
Meeting Highlights from the Third Annual Future of Supportive Therapy in Oncology San Francisco, CA • February 2005 27th Annual San Antonio Breast Cancer Symposium San Antonio, TX • December 2004 46th Annual Meeting of the American Society of Hematology San Diego, CA • December 2004
Pegfilgrastim: Recent Advances in the Prophylaxis of Chemotherapy-Induced Neutropenia
Novel Thrombopoetin Mimetic Agents with Potential to Ameliorate Chemotherapy-Induced Thrombocytopenia
Impact of Erythropoietic Agents on Survival of Anemic Patients with Cancer
Optimizing Management of Tumor Lysis Syndrome in Adults with Hematologic Malignancies
Patient Selection and Treatment of Tumor Lysis Syndrome in Adults with Hematologic Malignancies
A Primer in Prognostic and Predictive Models: Development and Validation of Neutropenia Risk Models
The Role of Methadone in the Treatment of Moderate to Severe Cancer Pain
Chemotherapy-Induced Emesis: Quality of Life and Economic Impact in the Context of Current Practice in Canada
Tumor Lysis Syndrome in Solid Tumors